TOP NEWS: GSK and Sanofi to use vaccine trial data for regulators
(Alliance News) - GlaxoSmithKline PLC on Wednesday said alongside Paris-based pharmaceutical giant Sanofi SA, it plans to submit data for both the booster and phase three efficacy trials as the base of regulatory applications for their Covid-19 vaccine. Read More